Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

5.05
-0.4000-7.34%
Post-market: 5.050.00000.00%19:48 EDT
Volume:1.52M
Turnover:7.68M
Market Cap:326.08M
PE:-3.97
High:5.52
Open:5.47
Low:4.92
Close:5.45
52wk High:10.08
52wk Low:1.10
Shares:64.57M
Float Shares:54.41M
Volume Ratio:2.04
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2729
EPS(LYR):-1.2729
ROE:-43.12%
ROA:-26.07%
PB:1.49
PE(LYR):-3.97

Loading ...

Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)

TIPRANKS
·
Mar 12

Immuneering price target lowered to $12 from $13 at Piper Sandler

TIPRANKS
·
Mar 09

Immuneering Price Target Maintained With a $11.00/Share by Needham

Dow Jones
·
Mar 09

BUZZ-U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT

Reuters
·
Mar 07

BUZZ-U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners

Reuters
·
Mar 06

BUZZ-U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences

Reuters
·
Mar 06

Shares of Immuneering Down 1.8% Premarket After Q4 Results

THOMSON REUTERS
·
Mar 06

BUZZ-Immuneering rises as quarterly loss comes in below estimates

Reuters
·
Mar 06

Immuneering posts smaller‑than‑expected Q4 loss on reduced R&D costs

Reuters
·
Mar 06

Immuneering reports Q4 EPS (18), consensus (31c)

TIPRANKS
·
Mar 06

Immuneering sees cash runway into 2029

TIPRANKS
·
Mar 06

Immuneering’s IMRX Q4 R&D expenses fall 37.7% to USD 9.3 million

Reuters
·
Mar 06

Immuneering Q4 EPS $(0.18) Beats $(0.31) Estimate

Benzinga
·
Mar 06

Immuneering Corp - Expects Cash Runway to Fund Operations Into 2029

THOMSON REUTERS
·
Mar 06

Immuneering Corp - Dosing in Phase 2 Trial of Atebimetinib + Libtayo in Nsclc Expected in 2H 2026

THOMSON REUTERS
·
Mar 06

Immuneering Corporation Q4 EPS USD -0.18 VS. Ibes Estimate USD -0.31

THOMSON REUTERS
·
Mar 06

Immuneering Corp - on Track for Expanded Pancreatic Cancer Cohort Data Readout in First Half of 2026

THOMSON REUTERS
·
Mar 06

Press Release: Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 06

Immuneering to Present at Leerink Global Healthcare Conference

Reuters
·
Mar 03

Top Immuneering Insider Quietly Ramps Up Stake in Bold New Buy

TIPRANKS
·
Jan 22